Skip to content
10-Q

Quarterly Report

NPS PHARMACEUTICALS INC

0001136261-14-000183

← back to feed
Filed
May 8, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 1, 2014 106.33M sh
Shares Diluted Q1 2014 · Mar 31, 2014 103.61M sh
Shares Diluted Q1 2014 · Mar 31, 2013 88.4M sh
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$6.67M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$9.32M
Long Term Debt Q1 2014 · Mar 31, 2014 $116.52M
Long Term Debt Q1 2014 · Dec 31, 2013 $123.64M
Short Term Debt Q1 2014 · Mar 31, 2014 $7.19M
Short Term Debt Q1 2014 · Dec 31, 2013 $8.75M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $53.23M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $51.2M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $19.36M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $17.47M
Stockholders Equity Q1 2014 · Mar 31, 2014 $105.35M
Stockholders Equity Q1 2014 · Dec 31, 2013 $104.89M
Current Liabilities Q1 2014 · Mar 31, 2014 $50.64M
Current Liabilities Q1 2014 · Dec 31, 2013 $58.41M
Total Liabilities Q1 2014 · Mar 31, 2014 $174.14M
Total Liabilities Q1 2014 · Dec 31, 2013 $187.33M
Current Assets Q1 2014 · Mar 31, 2014 $246.69M
Current Assets Q1 2014 · Dec 31, 2013 $258.75M
Total Assets Q1 2014 · Mar 31, 2014 $279.49M
Total Assets Q1 2014 · Dec 31, 2013 $292.22M
Eps Diluted Q1 2014 · Mar 31, 2014 −$0.06
Eps Diluted Q1 2014 · Mar 31, 2013 −$0.09
Eps Basic Q1 2014 · Mar 31, 2014 −$0.06
Eps Basic Q1 2014 · Mar 31, 2013 −$0.09
Sga Expense Q1 2014 · Mar 31, 2014 $24.55M
Sga Expense Q1 2014 · Mar 31, 2013 $14.21M
Rd Expense Q1 2014 · Mar 31, 2014 $20.56M
Rd Expense Q1 2014 · Mar 31, 2013 $15.7M
Net Income Q1 2014 · Mar 31, 2014 −$6.58M
Net Income Q1 2014 · Mar 31, 2013 −$7.8M
Operating Income Q1 2014 · Mar 31, 2014 −$2.95M
Operating Income Q1 2014 · Mar 31, 2013 −$4.53M
Cost Of Revenue Q1 2014 · Mar 31, 2014 $1.88M
Cost Of Revenue Q1 2014 · Mar 31, 2013 $65K
Revenue Q1 2014 · Mar 31, 2014 $44.04M
Revenue Q1 2014 · Mar 31, 2013 $25.43M